RBC Capital analyst Leonid Timashev lowered the firm’s price target on Pyxis Oncology (PYXS) to $8 from $10 and keeps an Outperform rating on the shares. The company’s pipeline update to prioritize ...
RBC BlueBay High Yield Bond Fund earns an Above Average Process Pillar rating. The predominant contributor to the rating is its parent firm's superior long-term risk-adjusted performance, as shown ...
Switch your mortgage to RBC and get up to $5,700 in value (up to $3,500 cash, a rebate in your switch fees of up to $1,100 and 55,000 Avion points). Terms and conditions apply. Offer available ...